KR100551501B1 - 스트론튬 라넬레이트 및 이의 수화물의 산업적 합성 방법 - Google Patents

스트론튬 라넬레이트 및 이의 수화물의 산업적 합성 방법 Download PDF

Info

Publication number
KR100551501B1
KR100551501B1 KR1020030065783A KR20030065783A KR100551501B1 KR 100551501 B1 KR100551501 B1 KR 100551501B1 KR 1020030065783 A KR1020030065783 A KR 1020030065783A KR 20030065783 A KR20030065783 A KR 20030065783A KR 100551501 B1 KR100551501 B1 KR 100551501B1
Authority
KR
South Korea
Prior art keywords
formula
compound
amount
iii
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020030065783A
Other languages
English (en)
Korean (ko)
Other versions
KR20040026625A (ko
Inventor
루실 바이세-루도트
쟌-피에르 레꾸브
파스칼 랑글로이스
Original Assignee
르 라보레또레 쎄르비에르
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 르 라보레또레 쎄르비에르 filed Critical 르 라보레또레 쎄르비에르
Publication of KR20040026625A publication Critical patent/KR20040026625A/ko
Application granted granted Critical
Publication of KR100551501B1 publication Critical patent/KR100551501B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Inorganic Insulating Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020030065783A 2002-09-24 2003-09-23 스트론튬 라넬레이트 및 이의 수화물의 산업적 합성 방법 Expired - Fee Related KR100551501B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0211763A FR2844795B1 (fr) 2002-09-24 2002-09-24 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR02.11763 2002-09-24

Publications (2)

Publication Number Publication Date
KR20040026625A KR20040026625A (ko) 2004-03-31
KR100551501B1 true KR100551501B1 (ko) 2006-02-13

Family

ID=29415189

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020030065783A Expired - Fee Related KR100551501B1 (ko) 2002-09-24 2003-09-23 스트론튬 라넬레이트 및 이의 수화물의 산업적 합성 방법

Country Status (37)

Country Link
US (1) US7214805B2 (enExample)
EP (1) EP1403266B1 (enExample)
JP (1) JP4136867B2 (enExample)
KR (1) KR100551501B1 (enExample)
CN (1) CN1212321C (enExample)
AP (1) AP1910A (enExample)
AR (1) AR041355A1 (enExample)
AU (2) AU2003282179A1 (enExample)
BR (1) BR0304213A (enExample)
CA (1) CA2442878C (enExample)
CR (1) CR7764A (enExample)
CY (1) CY1115162T1 (enExample)
DK (1) DK1403266T3 (enExample)
EA (1) EA007489B1 (enExample)
EC (1) ECSP055741A (enExample)
ES (1) ES2478620T3 (enExample)
FR (1) FR2844795B1 (enExample)
GE (1) GEP20074215B (enExample)
HR (1) HRP20050359B1 (enExample)
IL (1) IL167316A (enExample)
IS (1) IS7807A (enExample)
MA (1) MA26102A1 (enExample)
ME (1) ME00455B (enExample)
MX (1) MXPA03008643A (enExample)
MY (1) MY134921A (enExample)
NO (1) NO328638B1 (enExample)
NZ (1) NZ528402A (enExample)
OA (1) OA12934A (enExample)
PL (1) PL214400B1 (enExample)
PT (1) PT1403266E (enExample)
RS (2) RS53509B1 (enExample)
SG (1) SG110071A1 (enExample)
SI (1) SI1403266T1 (enExample)
TN (1) TNSN05087A1 (enExample)
UA (1) UA79156C2 (enExample)
WO (1) WO2004029036A1 (enExample)
ZA (1) ZA200307409B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098618A2 (en) * 2003-05-07 2004-11-18 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
PL1732575T3 (pl) 2004-02-26 2011-05-31 Osteologix As Związki zawierające stron do stosowania w zapobieganiu lub leczeniu stanów nekrotycznych kości
JP4954867B2 (ja) * 2004-05-06 2012-06-20 オステオロジックス エイ/エス 有機金属塩類を製造するための高収率で迅速な合成法
CA2571449C (en) 2004-06-25 2015-12-08 John Nikolaj Hvarre Christensen Compositions comprising strontium and vitamin d and uses thereof
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100538672C (zh) * 2005-04-18 2009-09-09 索尼株式会社 控制设备和方法
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
CA2619720A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
US9301945B2 (en) 2011-07-21 2016-04-05 Emory University Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102321068B (zh) * 2011-08-01 2013-01-23 山东铂源药业有限公司 一种雷奈酸锶的制备方法
WO2013175270A1 (en) * 2012-05-25 2013-11-28 Fleming Laboratories Limited Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
ES2505716T3 (es) 2013-01-21 2015-09-04 Galenicum Health S.L. Composiciones farmacéuticas que comprenden una sal de ácido
CN103319454B (zh) * 2013-06-14 2014-06-18 广东众生药业股份有限公司 一种高纯度雷尼酸四乙酯及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates

Also Published As

Publication number Publication date
AU2003282179A1 (en) 2004-04-19
TNSN05087A1 (fr) 2007-05-14
DK1403266T3 (da) 2014-07-07
AU2003248281B2 (en) 2009-08-06
ZA200307409B (en) 2004-07-07
AP1910A (en) 2008-10-30
ME00455B (me) 2011-10-10
CA2442878C (fr) 2009-03-03
CN1212321C (zh) 2005-07-27
FR2844795A1 (fr) 2004-03-26
ECSP055741A (es) 2005-07-06
HRP20050359B1 (hr) 2014-09-26
CR7764A (es) 2005-10-06
AU2003248281A1 (en) 2004-04-08
HRP20050359A2 (en) 2005-06-30
NO20034235D0 (no) 2003-09-23
EP1403266B1 (fr) 2014-04-09
JP4136867B2 (ja) 2008-08-20
KR20040026625A (ko) 2004-03-31
NO20034235L (no) 2004-03-25
OA12934A (en) 2006-10-13
BR0304213A (pt) 2004-08-31
CY1115162T1 (el) 2016-12-14
PL214400B1 (pl) 2013-07-31
PL362365A1 (en) 2004-04-05
FR2844795B1 (fr) 2004-10-22
PT1403266E (pt) 2014-05-06
IL167316A (en) 2008-08-07
US7214805B2 (en) 2007-05-08
AR041355A1 (es) 2005-05-11
EP1403266A1 (fr) 2004-03-31
NZ528402A (en) 2004-07-30
NO328638B1 (no) 2010-04-12
WO2004029036A1 (fr) 2004-04-08
RS53509B1 (sr) 2015-02-27
CA2442878A1 (fr) 2004-03-24
GEP20074215B (en) 2007-10-10
RS20050240A (sr) 2007-06-04
SG110071A1 (en) 2005-04-28
IS7807A (is) 2005-04-19
MA26102A1 (fr) 2004-04-01
ES2478620T3 (es) 2014-07-22
SI1403266T1 (sl) 2014-06-30
CN1496986A (zh) 2004-05-19
JP2004149516A (ja) 2004-05-27
EA007489B1 (ru) 2006-10-27
MXPA03008643A (es) 2005-04-19
MY134921A (en) 2008-01-31
HK1065791A1 (en) 2005-03-04
EA200300925A1 (ru) 2004-04-29
US20040063972A1 (en) 2004-04-01
UA79156C2 (en) 2007-05-25
AP2005003256A0 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
KR100551501B1 (ko) 스트론튬 라넬레이트 및 이의 수화물의 산업적 합성 방법
SU537625A3 (ru) Способ получени производных 1,1-диаминоэтилена
JP4136866B2 (ja) 5−〔ビス(カルボキシメチル)アミノ〕−3−カルボキシメチル−4−シアノ−2−チオフェンカルボン酸のテトラエステル類の新規な工業的合成方法、並びにラネリック酸の二価塩類及びそれらの水和物の合成への応用
JP2009132676A (ja) ストロンチウムラネレートおよびその水和物の新規な合成法
KR100551503B1 (ko) 5-아미노-3-카복시메틸-4-시아노-2-티오펜카르복실산의 산업적 합성 방법, 및 라넬산의 이가염 및 이의 수화물의 합성에의 적용
JP4408578B2 (ja) 3−(1−ヒドロキシ−ペンチリデン)−5−ニトロ−3h−ベンゾフラン−2−オン、その製造方法及びその用途
JPS63502903A (ja) 治療学的抗潰瘍活性を有する化合物の合成方法
CN112279805B (zh) 制备1-(3-甲氧基吡啶-2-基)-2-丙酮的方法
JP3899626B2 (ja) 2−メルカプトチアゾ−ルの製法
KR100297802B1 (ko) 2-(3-트리플루오로메틸)아닐리노니코틴산2-(n-몰포린)에틸의제조방법.
KR100209582B1 (ko) 고순도 2,3-디시아노-1,4-디티아 안트라퀴논의 제조방법
HK1061846B (en) New process for the industrial synthesis of substituted thiophene-carboxylates, and application of such compounds
HK1065791B (en) New process for the industrial synthesis of strontium ranelate and its hydrates
JPH06345737A (ja) ナファゾリンまたはその塩の製造方法

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20130109

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20131125

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20141222

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

FPAY Annual fee payment

Payment date: 20151202

Year of fee payment: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

FPAY Annual fee payment

Payment date: 20161129

Year of fee payment: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180207

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180207